| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.088 | 0.003 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.004 |